John W. Vance

778 total citations
23 papers, 629 citations indexed

About

John W. Vance is a scholar working on Pulmonary and Respiratory Medicine, Pharmacology and Oncology. According to data from OpenAlex, John W. Vance has authored 23 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 4 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in John W. Vance's work include Respiratory Support and Mechanisms (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). John W. Vance is often cited by papers focused on Respiratory Support and Mechanisms (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). John W. Vance collaborates with scholars based in United States and South Africa. John W. Vance's co-authors include Jerome J. Schentag, William J. Jusko, Jeffrey R. Koup, Mark Gardner, Antoinette Mangione, Thomas J. Cumbo, Louise M. Gerbracht, Elías Abrutyn, A. Ian Smith and Douglas J. Swanson and has published in prestigious journals such as CHEST Journal, The American Journal of Medicine and Journal of Pharmaceutical Sciences.

In The Last Decade

John W. Vance

21 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John W. Vance United States 10 305 150 110 105 99 23 629
J.M. Brogard France 14 308 1.0× 119 0.8× 87 0.8× 119 1.1× 106 1.1× 63 672
J P Fillastre France 18 477 1.6× 100 0.7× 129 1.2× 218 2.1× 199 2.0× 75 1.0k
L Dettli Switzerland 14 277 0.9× 114 0.8× 200 1.8× 85 0.8× 53 0.5× 51 874
Mark A. Gill United States 17 422 1.4× 105 0.7× 78 0.7× 199 1.9× 157 1.6× 60 987
Susan Willavize United States 14 232 0.8× 109 0.7× 94 0.9× 183 1.7× 116 1.2× 31 653
Andrew D. Blair United States 16 270 0.9× 126 0.8× 156 1.4× 163 1.6× 55 0.6× 31 901
EJ Begg New Zealand 13 283 0.9× 58 0.4× 214 1.9× 178 1.7× 64 0.6× 19 851
C E Halstenson United States 14 390 1.3× 40 0.3× 110 1.0× 191 1.8× 91 0.9× 28 836
Kenneth E. Record United States 14 261 0.9× 65 0.4× 72 0.7× 111 1.1× 40 0.4× 33 693
T. B. Tjandramaga Belgium 15 373 1.2× 42 0.3× 179 1.6× 66 0.6× 72 0.7× 41 818

Countries citing papers authored by John W. Vance

Since Specialization
Citations

This map shows the geographic impact of John W. Vance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Vance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Vance more than expected).

Fields of papers citing papers by John W. Vance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Vance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Vance. The network helps show where John W. Vance may publish in the future.

Co-authorship network of co-authors of John W. Vance

This figure shows the co-authorship network connecting the top 25 collaborators of John W. Vance. A scholar is included among the top collaborators of John W. Vance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John W. Vance. John W. Vance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cordasco, Edward M., et al.. (1995). Noncardiac Pulmonary Edema, Newer Environmental Aspects. Angiology. 46(9). 759–766. 4 indexed citations
2.
Schentag, Jerome J., Alan Forrest, Thomas F. Goss, et al.. (1993). Ciprofloxacin Eradicates Respiratory Tract Bacteria More Rapidly than Cephalosporins in Patients with Nosocomial Pneumonia†. Drugs. 45(Supplement 3). 473–473. 1 indexed citations
3.
Nix, David E., Mark F. Sands, Charles A. Peloquin, et al.. (1987). Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections.. PubMed. 82(4A). 352–6. 33 indexed citations
4.
Schentag, Jerome J., et al.. (1984). Complexation versus Hemodialysis To Reduce Elevated Aminoglycoside Serum Concentrations. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 4(6). 374–380. 3 indexed citations
5.
Vance, John W., et al.. (1982). The transmural gastric potential difference in combination with pharmacokinetic profiles. A new approach to combine kinetic and dynamic properties of compounds.. PubMed. 4(7). 533–8. 1 indexed citations
6.
Jusko, William J., Mark Gardner, Antoinette Mangione, et al.. (1979). Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol. Journal of Pharmaceutical Sciences. 68(11). 1358–1366. 201 indexed citations
7.
Vance, John W.. (1978). RESPIRATORY CARE: A GUIDE TO CLINICAL PRACTICE. CHEST Journal. 74(4). 32–36. 5 indexed citations
8.
Schentag, Jerome J., William J. Jusko, John W. Vance, et al.. (1977). Gentamicin disposition and tissue accumulation on multiple dosing. Journal of Pharmacokinetics and Biopharmaceutics. 5(6). 559–577. 116 indexed citations
9.
Koup, Jeffrey R., et al.. (1976). System for Clinical Pharmacokinetic Monitoring of Theophylline Therapy. American Journal of Health-System Pharmacy. 33(9). 949–957. 9 indexed citations
10.
Koup, Jeffrey R., et al.. (1976). System for clinical pharmacokinetic monitoring of theophylline therapy.. PubMed. 33(9). 949–56. 36 indexed citations
11.
Beerel, F R, John W. Vance, & Thomas L. Petty. (1970). A Simplified Method for Presenting Acid-Base Balance Situations. CHEST Journal. 57(5). 480–484. 1 indexed citations
12.
Beerel, F R, et al.. (1969). Reliability of determinations of oxygen tension from arterialized capillary blood from the tip of a finger.. PubMed. 99(1). 121–2. 1 indexed citations
13.
Cordasco, Edward M., et al.. (1968). Newer Aspects of the Pulmonary Vasculature in Chronic Lung Disease. Angiology. 19(7). 399–407. 24 indexed citations
14.
Vance, John W.. (1967). Management of patients with cor pulmonale—Acute and chronic. Progress in Cardiovascular Diseases. 9(5). 470–487.
15.
Vance, John W.. (1966). Stores of Carbon Dioxide in Emphysema. Diseases of the Chest. 49(2). 147–154. 2 indexed citations
16.
Beerel, F R & John W. Vance. (1965). Daily Pco-2 and pH fluctuations in pulmonary emphysema with carbon dioxide retention.. PubMed. 92(6). 894–9. 4 indexed citations
17.
Cordasco, Edward M., et al.. (1965). Pulmonary Edema of Noncardiac Origin. Archives of Environmental Health An International Journal. 11(4). 588–596. 6 indexed citations
18.
Vance, John W.. (1963). A Bellows-type Spirometer for Measuring the Forced Expirogram. Diseases of the Chest. 43(1). 57–61. 8 indexed citations
19.
20.
Vance, John W., C. Allen Good, Corrin H. Hodgson, John W. Kirklin, & Robert P. Gage. (1959). The Solitary Circumscribed Pulmonary Lesion Due to Bronchogenic Carcinoma: a 3-year Follow-up Study of 94 Surgically Treated Patients. Diseases of the Chest. 36(3). 231–237. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.M. Brogard Breakdown of academic impact, for papers by J P Fillastre Breakdown of academic impact, for papers by L Dettli Breakdown of academic impact, for papers by Mark A. Gill Breakdown of academic impact, for papers by Susan Willavize Breakdown of academic impact, for papers by Andrew D. Blair Breakdown of academic impact, for papers by EJ Begg Breakdown of academic impact, for papers by C E Halstenson Breakdown of academic impact, for papers by Kenneth E. Record Breakdown of academic impact, for papers by T. B. Tjandramaga
Rankless by CCL
2026